Protara Therapeutics (TARA) Financials

$3.79

$-0.04 (-1.04%)

As on 10-Sep-2026 16:00EDT

Market cap

$233 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

1.5

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	0.27	0.36	0.33	0.34	0.25	1.17
Gross Profit	-0.27	-0.36	-0.33	-0.34	-0.25	-1.17
Operating Expenses	76.70	64.19	49.15	43.27	67.06	47.49
Operating Profit (EBIT)	-76.79	-64.55	-49.15	-43.61	-67.06	-47.49
Other Income	--	--	--	--	--	--
Profit before Tax	-70.02	-57.44	-44.60	-40.42	-65.95	-47.25
Provision for Tax	--	--	--	-0.34	-1.14	-0.12
Profit after Tax (Net Income)	-70.02	-57.44	-44.60	-40.42	-65.95	-47.25
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-65.95	-47.25

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	161.31	196.41	167.13	68.32	102.08	161.91
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	1.46	2.12	3.36	4.48	5.47	6.38
Current Liabilities	13.32	10.94	10.96	6.15	5.74	4.30
Total Liabilities	189.41	209.47	181.45	78.95	113.29	172.60

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	29.94	49.96	9.30	10.25	27.14	79.48
Current Assets	146.15	159.50	172.16	68.71	86.15	93.11
Total Assets	189.41	209.47	181.45	78.95	113.29	172.60
Total Debt*	2.75	3.36	4.48	5.47	6.38	7.24
Net Current Assets	132.83	148.57	161.19	62.56	80.41	88.81

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-56.37	-35.81	-37.56	-26.46	-34.50
Cash Flow from Investing Activities	--	-139.49	19.16	53.11	14.95	-98.19
Cash from Financing Activities	--	82.72	139.87	-0.09	-0.09	-0.23
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-1.35	-1.25	-1.69	-3.56	-5.85	-4.21
Cash EPS ($)	--	-1.24	-1.67	-3.53	-5.83	-4.20
Adjusted Book Value ($)	--	4.27	6.32	6.01	9.06	14.41
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-1.22	-1.35	-3.30	-2.35	-3.07
Free Cash Flow per Share ($)	--	-1.23	-1.36	-3.31	-2.36	-3.12

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-30.93	-36.34	-44.36	-47.51	-25.58
ROE (%)	-39.14	-31.60	-37.88	-47.44	-49.96	-26.17
ROA (%)	-39.32	-29.39	-34.25	-42.05	-46.14	-25.15
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	-37.66	-28.80	-10.33	37.64	-42.40	-33.95
Net Profit Growth (%)	-37.66	-28.80	-10.33	38.71	-39.58	-39.07
EPS Growth (%)	17.05	0.26	0.53	0.39	-0.39	-0.39
Book Value Growth (%)	-22.61	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-4.27	-3.13	-0.53	-0.46	-1.61
Price / Book Value	1.45	1.25	0.84	0.31	0.30	0.47
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.74	-1.63	0.59	0.97	0.74	0.18
Close Price ($)	3.82	5.33	5.28	1.88	2.68	6.75
High Price ($)	7.82	7.82	10.48	4.18	7.15	25.20
Low Price ($)	2.77	2.77	1.60	1.04	2.38	5.94
Market Cap ($ Cr)	232.84	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.02	0.03	0.08	0.06	0.04
Short term debt to equity ratio	0.01	0.01	0.01	0.01	0.01	0.01
Current Ratio	10.97	14.58	15.71	11.17	15.01	21.66
Quick Ratio	10.97	--	--	--	14.81	21.38
Interest Coverage	-19.91	--	-10.69	--	-57.01	-26.20

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	--	1,245.71	1,758.23	380.27
Payable days	--	3,983.95	3,775.17	2,152.94	1,878.01	292.33
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.